DELCADE announces the appointment of Kevin Poujol as Partner
On January 8, 2025 By Kevin POUJOL
DELCADE is proud to announce the appointment of Kevin Poujol as a Partner. This advancement strengthens the firm’s growth and innovation dynamic, reinforcing its commitment to businesses and entrepreneurs.
A member of the Paris Bar since 2016, Kevin Poujol joined DELCADE in 2022 as Counsel. Working closely with Benoît Lafourcade, he advises and litigates in various areas of business law, including Corporate, M&A, Private Equity, and insolvency proceedings.
Holding a Master’s degree in Business Law from the University of Paris 1 Panthéon-Sorbonne, Kevin is fluent in both French and English, allowing him to combine an international approach with his legal expertise.
A key milestone for DELCADE
This appointment marks a new milestone for DELCADE, which remains committed to fostering talents like Kevin to support businesses in today’s and tomorrow’s challenges. “Kevin perfectly embodies the spirit of the firm: expertise, innovation, and dedication to our clients,” say DELCADE co-founders Fabrice Delouis and Benoît Lafourcade.
Our latest news
Coordination of pension schemes: what legal framework applies to international careers?
International workforce mobility involves a complex interplay between several national social security systems. In terms of retirement, this raises major legal questions: which legislation applies to a posted or expatriate employee? How are their acquired rights preserved from one country to another? Under what terms will their pension ultimately be settled? These are questions our […]
Read
Shadow Payroll and International Assignments in France: a compliance guide for foreign employers
Foreign companies deploying employees or executives to France face a layered set of obligations that span employment law, payroll reporting, taxation, social security coordination, and immigration procedures. Managing these requirements in isolation — through separate providers across different jurisdictions — often leads to gaps, duplications, or costly errors. DELCADE’s International Assignment Services practice offers a […]
Read
DELCADE advises Geistlich Pharma AG on taking control of OST Développement
The European regenerative medicine market continues to consolidate. On 24 April 2026, the Swiss group Geistlich Pharma AG completed the acquisition of a majority stake in OST Développement, a French specialist in bone regeneration. DELCADE acted as legal counsel to the acquirer, extending a collaboration that began back in 2024. A two-stage M&A move The […]
Read